Involvement of potential pathways in malignant transformation from oral leukoplakia to oral squamous cell carcinoma revealed by proteomic analysis

BMC Genomics

Volumn 10, Issue , 2009, Pages 383-

  Wang, Zhi ^a   Feng, Xiaodong ^a   Liu, Xinyu ^b   Jiang, Lu ^a   Zeng, Xin ^a   Ji, Ning ^a   Li, Jing ^a   Li, Longjiang ^a   Chen, Qianming ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEASOME; PROTEASOME ACTIVATOR 28; PROTEASOME ACTIVATOR 28 A; PROTEASOME ACTIVATOR 28 B; PROTEASOME ACTIVATOR 28 G; TUMOR MARKER; UNCLASSIFIED DRUG; MUSCLE PROTEIN; PSME1 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; ARTICLE; CARCINOGENESIS; DOWN REGULATION; DYSPLASIA; GENE CONTROL; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; LEUKOPLAKIA; LIQUID CHROMATOGRAPHY; MALIGNANT TRANSFORMATION; MASS SPECTROMETRY; MOUTH CARCINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEOMICS; SQUAMOUS CELL CARCINOMA; TWO DIMENSIONAL ELECTROPHORESIS; UNINDEXED SEQUENCE; UPREGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; MOUTH TUMOR; PATHOLOGY; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKOPLAKIA, ORAL; MOUTH NEOPLASMS; MUSCLE PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 70349582733     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-10-383     Document Type: Article

References (42)

1. Saranath D, . (Ed) Contemporary Issues in Oral Cancer. 2000, 30-71. Oxford University Press, New Delhi.
2. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, Benner SE, Xu XC, Lee JS, Papadimitrakopoulou VM, Geyer C, Perez C, Martin JW, El-Naggar AK, Lippman SM. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res 2000, 6:1702-1710.
3. Jaber MA, Porter SR, Speight P, Eveson JW, Scully C. Oral epithelial dysplasia: clinical characteristics of western European residents. Oral Oncol 2003, 39:589-96. 10.1016/S1368-8375(03)00045-9, 12798402.
4. Koike H, Uzawa K, Nakashima D, Shimada K, Kato Y, Higo M, Kouzu Y, Endo Y, Kasamatsu A, Tanzawa H. Identification of differentially expressed proteins in oral squamous cell carcinoma using a global proteomic approach. Int J Oncol 2005, 27:59-67.
5. Kato H, Uzawa K, Onda T, Kato Y, Saito K, Nakashima D, Ogawara K, Bukawa H, Yokoe H, Tanzawa H. Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A protein expression in oral squamous cell carcinoma. Int J Oncol 2006, 28:873-81.
6. He QY, Chen J, Kung HF, Yuen AP, Chiu JF. Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 2004, 4:271-8. 10.1002/pmic.200300550, 14730689.
7. Balys R, Alaoui-Jamali M, Hier M, Black M, Domanowski G, Rochon L, Jie S. Clinically relevant oral cancer model for serum proteomic eavesdropping on the tumour microenvironment. J Otolaryngol 2006, 35:157-166.
8. Xie H, Onsongo G, Popko J, de Jong EP, Cao J, Carlis JV, Griffin RJ, Rhodus NL, Griffin TJ. Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. Mol Cell Proteomics 2008, 7:486-498.
9. Hu S, Arellano M, Boontheung P. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 2008, 14:6246-6252. 10.1158/1078-0432.CCR-07-5037, 18829504.
10. Jacob RJ, Cramer R. PIGOK: Linking protein identity to gene ontology and function. J Proteome Res 2006, 5:3429-3432. 10.1021/pr0601537, 17137344.
11. Koehn J, Krapfenbauer K, Huber S, Stein E, Sutter W, Watzinger F, Erovic BM, Thurnher D, Schindler T, Fountoulakis M, Turhani D. Potential involvement of MYC- and p53-related pathways in tumorigenesis in human oral squamous cell carcinoma revealed by proteomic analysis. J Proteome Res 2008, 7:3818-3829. 10.1021/pr800077a, 18700792.
12. Garcia Pedrero JM, Fernandez MP, Morgan RO, Herrero Zapatero A, Gonzalez MV, Suarez Nieto C, Rodrigo JP. Annexin A1 downregulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol 2004, 164:73-79. 1602219, 14695321.
13. Kasamatsu A, Uzawa K, Nakashima D, Kouzu Y, Endo Y, Koike H, Yokoe H, Harada K, Sato M, Tanzawa H. A proteomics approach to characterizing human submandibular gland cell lines by fluorescent two-dimensional differential in-gel electrophoresis. Int J Mol Med 2006, 17:253-260.
14. Zimmermann U, Balabanov S, Giebel J, Teller S, Junker H, Schmoll D, Protzel C, Scharf C, Kleist B, Walther R. Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination. Cancer Lett 2004, 209:111-118. 10.1016/j.canlet.2003.12.002, 15145526.
15. Duncan R, Carpenter B, Main LC, Telfer C, Murray GI. Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer 2008, 98:426-433. 10.1038/sj.bjc.6604128, 18071363.
16. Corsten MF, Hofstra L, Narula J, Reutelingsperger CP. Counting heads in the war against cancer: defining the role of annexin A5 imaging in cancer treatment and surveillance. Cancer Res 2006, 66:1255-1260. 10.1158/0008-5472.CAN-05-3000, 16452175.
17. Stein T, Price KN, Morris JS, Heath VJ, Ferrier RK, Bell AK, Pringle MA, Villadsen R, Petersen OW, Sauter G, Bryson G, Mallon EA, Gusterson BA. Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer. Clin Cancer Res 2005, 11:6872-6879. 10.1158/1078-0432.CCR-05-0547, 16203777.
18. Karanjawala ZE, Illei PB, Ashfaq R, Infante JR, Murphy K, Pandey A, Schulick R, Winter J, Sharma R, Maitra A, Goggins M, Hruban RH. New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8. Am J Surg Pathol 2008, 32:188-96. 10.1097/PAS.0b013e31815701f3, 2678811, 18223320.
19. Madsen P, Rasmussen HH, Leffers H, Honoré B, Celis JE. Molecular cloning and expression of a novel keratinocyte protein (psoriasisassociated fatty acid-binding protein [PA-FABP]) that is highly up-regulated in psoriatic skin and that shares similarity to fatty acidbinding proteins. J Invest Dermatol 1992, 99:299-305. 10.1111/1523-1747.ep12616641, 1512466.
20. Celis JE, Rasmussen HH, Vorum H, Madsen P, Honoré B, Wolf H, Orntoft TF. Bladder squamous cell carcinomas express psoriasin and externalize it to the urine. J Urol 1996, 155:2105-12. 10.1016/S0022-5347(01)66118-4, 8618345.
21. Moubayed N, Weichenthal M, Harder J, Wandel E, Sticherling M, Gläser R. Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours. J Cancer Res Clin Oncol 2007, 133:253-261. 10.1007/s00432-006-0164-y, 17136347.
22. Emberley ED, Niu Y, Njue C, Kliewer EV, Murphy LC, Watson PH. Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer. Clin Cancer Res 2003, 9:2627-2631.
23. Kesting MR, Sudhoff H, Hasler RJ, Nieberler M, Pautke C, Wolff KD, Wagenpfeil S, Al-Benna S, Jacobsen F, Steinstraesser L. Psoriasin (S100A7) up-regulation in oral squamous cell carcinoma and its relation to clinicopathologic features. Oral Oncol 2009, 45(8):731-6. 19147391, 10.1016/j.oraloncology.2008.11.012.
24. Zhou G, Xie TX, Zhao M, Jasser SA, Younes MN, Sano D, Lin J, Kupferman ME, Santillan AA, Patel V, Gutkind JS, Ei-Naggar AK, Emberley ED, Watson PH, Matsuzawa SI, Reed JC, Myers JN. Reciprocal negative regulation between S100A7/psoriasin and beta-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity. Oncogene 2008, 27:3527-3538. 10.1038/sj.onc.1211015, 18223693.
25. Hermani A, De Servi B, Medunjanin S, Tessier PA, Mayer D. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res 2006, 312:184-197. 10.1016/j.yexcr.2005.10.013, 16297907.
26. Stulík J, Koupilova K, Osterreicher J, Knízek J, Macela A, Bures J, Jandík P, Langr F, Dedic K, Jungblut PR. Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma. Electrophoresis 1999, 20:3638-3646. 10.1002/(SICI)1522-2683(19991201)20:18<3638::AID-ELPS3638>3.0 CO;2-W, 10612291.
27. Arai K, Takano S, Teratani T, Ito Y, Yamada T, Nozawa R. S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast. Curr Cancer Drug Targets 2008, 8:243-52. 10.2174/156800908784533445, 18537548.
28. Lo WY, Lai CC, Hua CH, Tsai MH, Huang SY, Tsai CH, Tsai FJ. S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining. J Proteome Res 2007, 6:2143-2151. 10.1021/pr060551+, 17451265.
29. Cross SS, Hamdy FC, Deloulme JC, Rehman I. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 2005, 46:256-269. 10.1111/j.1365-2559.2005.02097.x, 15720411.
30. Rehman I, Azzouzi AR, Cross SS, Deloulme JC, Catto JW, Wylde N, Larre S, Champigneuille J, Hamdy FC. Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions. Hum Pathol 2004, 35:1385-1391. 10.1016/j.humpath.2004.07.015, 15668896.
31. Kornberg LJ, Villaret D, Popp M, Lui L, McLaren R, Brown H, Cohen D, Yun J, McFadden M. Gene expression profiling in squamous cell carcinoma of the oral cavity shows abnormalities in several signaling pathways. Laryngoscope 2005, 115:690-698.
32. Sturchler E, Cox JA, Durussel I, Weibel M, Heizmann CW. S100A16, a novel calcium-binding protein of the EF-hand superfamily. J Biol Chem 2006, 281:38905-38917. 10.1074/jbc.M605798200, 17030513.
33. Ciechanover A, Orian A, Schwartz AL. Ubiquitin-mediatedproteolysis: biological regulation via destruction. Bioessays 2000, 22:442-451. 10.1002/(SICI)1521-1878(200005)22:5<442::AID-BIES6>3.0 CO;2-Q, 10797484.
34. Hill CP, Masters EI, Whitby FG. The 11S regulators of 20S proteasome activity. Curr Top Microbiol Immunol 2002, 268:73-89.
35. Watts C. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nat Immunol 2004, 5:685-692. 10.1038/ni1088, 15224094.
36. Yewdell JW, Reits E, Neefjes J. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat Rev Immuno 2003, 3:952-961.
37. Nikaido T, Shimada K, Nishida Y, Lee RS, Pardee AB, Nishizuka Y. Loss in transformed cells of cell cycle regulation of expression of a nuclear protein recognized by SLE patient antisera. Exp Cell Res 1989, 182:284-289. 10.1016/0014-4827(89)90299-1, 2541006.
38. Barton LF, Runnels HA, Schell TD, Cho Y, Gibbons R, Tevethia SS, Deepe GS, Monaco JJ. Immune defects in 28-kDa proteasome activator gamma-deficient mice. J Immunol 2004, 172(6):3948-54. 15004203.
39. Sobin LH, Wittekind C, . (eds) UICC TNM Classification of Malignant Tumors. 2002, John Wiley and Sons, Inc., NewYork, 6.
40. Wang Z, Jiang L, Huang C, Li Z, Chen L, Gou L, Chen P, Tong A, Tang M, Gao F, Shen J, Zhang Y, Bai J, Zhou M, Miao D, Chen Q. Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma. Mol Cell Proteomics 2008, 7:1639-1650. 10.1074/mcp.M700520-MCP200, 18458027.
41. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence database using mass spectrometric data. Electrophoresis 1999, 20:3551-3567. 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0 CO;2-2, 10612281.
42. Kornberg LJ, Villaret D, Popp M, Lui L, McLaren R, Brown H, Cohen D, Yun J, McFadden M. Gene expression profiling in squamous cell carcinoma of the oral cavity shows abnormalities in several signaling pathways. Laryngoscope 2005, 115:690-8.